Infectious cancer in mussels spread across the Atlantic

November 05, 2019

An infectious cancer that originated in one species of mussel growing in the Northern Hemisphere has spread to related mussels in South America and Europe, says a new study published today in eLife.

The findings also suggest that humans may unwittingly be contributing to the worldwide spread of infectious cancers that can affect mussels and other bivalves such as clams and cockles.

Most cancers arise when DNA mutations occur in an organism's cells that cause uncontrolled cell growth. While these cancerous cells do not normally spread to others, there are a few exceptions.

"Tasmanian devils, dogs and bivalves have all developed cancers that can spread to others, acting more like a pathogen or parasite," explains lead author Marisa Yonemitsu, Research Technician at the Pacific Northwest Research Institute in Seattle, Washington, US. One such cancer, called a bivalve transmissible neoplasia, was previously found in a species of mussel called Mytilus trossulus (M. trossulus) that lives in British Columbia, Canada. Similar diseases have also been reported in related mussel species around the world, but it was not known if they were transmissible too.

In the current study, Yonemitsu and her colleagues sequenced DNA from cancer cells in the related species M. edulis, from France and the Netherlands, and M. chilensis, which lives on the coasts of Chile and Argentina. They wanted to determine whether the cancers are transmissible neoplasias and, if so, whether they were from the same lineage as the one in M. trossulus, or if these species had transmissible cancers of their own. "This would help us understand how often transmissible cancers can occur, how far they can spread in nature and whether they are able to affect new populations and new species," Yonemitsu explains.

Unexpectedly, the team discovered that cancer cells collected in mussels from Europe and South America were nearly identical genetically, suggesting they came from a common origin - likely a single M. trossulus mussel with a primary cancer at some point in the past. Their analysis also revealed that this lineage of cancer is different from the one previously observed in Canada. This shows that transmissible cancer cells evolved more than once in M. trossulus, and in one case these cancer cells were transferred across the Atlantic Ocean and infected multiple species across the world.

"Since Mytilus mussels do not live in the equatorial zone, it would have been nearly impossible for them to have spread this cancer between South America and the Northern Hemisphere on their own," notes senior author Michael Metzger, Assistant Investigator at the Pacific Northwest Research Institute. Instead, he says it is likely they were transported accidentally on international shipping vessels.

"Our study shows that infectious cancers in bivalves are widespread pathogens and that human intervention may be responsible for introducing them into new susceptible populations and species," Metzger concludes. "Further studies will allow us to learn more about how these cancers evolve when introduced into new host species and how the hosts themselves can evolve in response."

The paper 'A single clonal lineage of transmissible cancer identified in two marine mussel species in South America and Europe' can be freely accessed online at Contents, including text, figures and data, are free to reuse under a CC BY 4.0 license.

Media contact

Emily Packer, Senior Press Officer
01223 855373

About eLife

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours in science. We publish important research in all areas of the life and biomedical sciences, including Cancer Biology and Microbiology and Infectious Disease, which is selected and evaluated by working scientists and made freely available online without delay. eLife also invests in innovation through open-source tool development to accelerate research communication and discovery. Our work is guided by the communities we serve. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, the Wellcome Trust and the Knut and Alice Wallenberg Foundation. Learn more at

To read the latest Cancer Biology research published in eLife, visit

And for the latest in Microbiology and Infectious Disease, see


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to